AlphaQuest’s Pacira BioSciences PCRX Stock Holding History

AlphaQuest’s Portfolio PCRX Stock Details PCRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-9,304	Closed	-$241K	–	1474
2025 Q4	$241K	Sell	9,304 -2,941	-24%	-$69.9K	0.01%	1355
2025 Q3	$316K	Sell	12,245 -2,293	-16%	-$56.3K	0.02%	1124
2025 Q2	$347K	Sell	14,538 -4,982	-26%	-$126K	0.03%	802
2025 Q1	$485K	Buy	19,520 +6,027	+45%	+$144K	0.05%	532
2024 Q4	$254K	Buy	13,493 +4,083	+43%	+$71.7K	0.03%	775
2024 Q3	$142K	Buy	9,410 +5,449	+138%	+$93.2K	0.01%	1196
2024 Q2	$113K	Buy	+3,961	New	+$113K	0.02%	900
2024 Q1	–	Sell	-3,711	Closed	-$125K	–	1761
2023 Q4	$125K	Buy	+3,711	New	+$109K	0.03%	721

Other funds holding PCRX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

DPCM

Doma Perpetual Capital Management Miami, Florida $431M AUM 13.21% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

AlphaQuest's PCRX Position: Q1 2026 in Review

AlphaQuest sold out of Pacira BioSciences (PCRX) in Q1 2026, closing a stake of 9,304 shares — an estimated $241K sold.

AlphaQuest first reported a position in PCRX in Q4 2023 and held it in 8 quarters. The position peaked at $485K in Q1 2025. 242 funds tracked by Wall St. Rank hold PCRX as of Q1 2026.

AlphaQuest reported no remaining Pacira BioSciences position as of Q1 2026 after selling out during the quarter.
AlphaQuest sold 9,304 Pacira BioSciences shares in Q1 2026, an estimated $241K.
AlphaQuest first reported a position in Pacira BioSciences in Q4 2023 and held it in 8 quarters.
AlphaQuest's Pacira BioSciences position peaked at $485K in Q1 2025.
242 funds tracked by Wall St. Rank held Pacira BioSciences as of Q1 2026.

Based on AlphaQuest's 13F filing for Q1 2026.